| PERIOD ENDING | 28-Mar-09 | 29-Mar-08 | 31-Mar-07 | | Total Revenue | 5,018,900 | 4,880,100 | 4,295,400 | | Cost of Revenue | 2,288,200 | 2,242,000 | 1,959,200 | | | Gross Profit | 2,730,700 | 2,638,100 | 2,336,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,036,000 | 1,932,500 | 1,663,400 | | Non Recurring | 79,000 | 5,000 | 4,600 | | Others | 20,200 | 47,200 | 15,600 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 595,500 | 653,400 | 652,600 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 23,600 | 18,300 | 24,600 | | Earnings Before Interest And Taxes | 614,100 | 667,800 | 664,900 | | Interest Expense | 26,600 | 25,700 | 21,600 | | Income Before Tax | 587,500 | 642,100 | 643,300 | | Income Tax Expense | 181,500 | 222,300 | 242,400 | | Minority Interest | (5,000) | (2,100) | (15,300) | | | | Net Income From Continuing Ops | 406,000 | 419,800 | 400,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 406,000 | 419,800 | 400,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $406,000 | $419,800 | $400,900 |
|
1.48% Nasdaq 
Income Statement
